Professional Documents
Culture Documents
Gitelman Syndrome Gitelman Syndrome: Case Report Nephrology Division Case Report Nephrology Division
Gitelman Syndrome Gitelman Syndrome: Case Report Nephrology Division Case Report Nephrology Division
Nephrology Division
GITELMAN SYNDROME
Pediatric Department
Medical Faculty
Hasanuddin University
INTRODUCTION
GITELMAN SYNDROME
Characterized by
hypokalemic metabolic
alkalosis and combination
Familial hYpokalemia-
with significant Autosomal recessive
hypomagnesemia
hypomagnesemia and low
urinary calcium excretion.
(Blanchard, 2017)
Prevalence is estimated around 1: 40.000
07/20/2020 3
Clinical Symptoms
4
CASE REPORT
• PATIENT IDENTITY
• Name : An. KDU
• Medical record : 81-90-54
• Date of birth : 20-08-2004
• Age : 14 years
• Gender : Female
• Weight : 31.5 kg
• Height : 151 cm
• Admission date in ER : 20-08 -2019
• Address : BTN Citra Manggali
permai
07/20/2020 5
Father Mother
Name M M
07/20/2020 6
Anamnesis
7
History of fever for 1 day at 4 days before hospitalization and down after given heat-
lowering drugs.
History of patients often feel thirsty, fatigue, frequently urinate at night.
3-day treatment history of Bahagia Hospital with hypokalaemia and acute kidney
failure and got treatment KCL 7.4%
A history of being treated at Wahidin Hospital in 2017 with the same complaint and
diagnosed with hypokalemia with potassium 1.5 mmol / L, with the results of a CT
scan of the abdominal gall bladder sludge accompanied by cholelithiasis.
History of family members with the same complaint is the sister of the patient's
mother who often experience hypokalemia.
8
PHYSICAL EXAMINATION
Extremities : Wasting
Motoric
5 5
4 4
07/20/2020 9
Anthropometry
Body Weight (BW) • : 31,5 kg
Height (H) • : 151 cm
Head circumference • : 54 cm (Normal 52-58cm)
chest circumference • : 71 cm
Abdominal circumference • : 55 cm
BW/H • : 73,8% (Undernourished)
H/A • : 95,1% (Normal stature)
10
Supporting Investigation
Urinalysis ( 13/5/2019)
Yellow color, SG <1.005, negative
protein, negative glucose,
negative ketone, negative nitrite,
negative leukocyte.
11
DIAGNOSIS
Cholelithiasis
Hypokalemia
Hyponatremia
Leukocytosis
Nutritional marasmus
Inferior paraparesis
12
Bolus Kcl 7.4% 24 meq in
dextrose 5% in 8 hours
Management of
malnutrition stabilization
phase day 1
Ondansetron 7 mg / 8
hours / intravenously
Multivitamin
13
• Complaints: There is a weakness in the inferior
limb
07/20/2020 14
USG ABDOMEN
07/20/2020 15
• Day 3 of treatment
• S: no weakness in
inferior extremity
• MSCT scan Urography:
• Cholelitiasis
• Minimal bilateral
callectasis e.c distended
vesica urinaria and
hydronephrosis
MSCT scan Urografi
• Spina bifida os sacrum
07/20/2020 16
Day 8 of Treatment
No chieft Compalian
Leukosit 17.430, Ureum 12, creatinin 0,52, SGOT 73l, SGPT 129, Alakali fosfatase n544 U/L(N<240),
calcium 7,9mg/dl(N), magnesium 1,92(N), Natrium 133(N), Kalium 2,2,
Ft4 1,45(N), Tshs 2,62(N)
Normal Xray Thoraks
Normal ECG
Assesment:
Kolelitiasis
Hipokalemia
Hiponatremia
Leukositosis
Nutritional marasmus
Hidronefrosis bilateral
Planning:
Koreksi kalium dengan kcl 7,4%, Urdafalk 250 mg/8jam/oral,
Other therapies are continued
07/20/2020 17
ECG
X-ray Thorax PA Position
07/20/2020 18
• 11thth day of treatmet Complaints:
nothing
Laboratory:
• Leukocytes 14.770,
• Ureum 24, creatinine 0,9, SGOT 32,
• SGPT 31, Sodium 135, Potassium 2.0.
• Therapy is continued Day 14 care
Complaints: nothing
Laboratory: Urine Calcium 76.3 mg / 24
hours (N 100-320)
Diagnosis: Gittelman syndrome
Therapy: KSR and urdafalk. Management of
malnutrition and Outpatients
07/20/2020 19
Definitive diagnosis
• Gitelman syndrome
• Bilateral hydronephrosis
• Acute kidney injury
• Cholelithiasis
• Hypokalemia
• Hyponatremia
• Leukocytosis
• Nutritional marasmus
• Inferior paraparese
• Increased trans aminase
enzymes
20
• • PROGNOSIS
PROGNOSIS
• • Qua
QuaAdAdvitam
vitam: bonam
: bonam
• • Qua
QuaAdAdsanationam
sanationam: bonam
: bonam
• • Qua
QuaAdAdfungsionam
fungsionam: bonam
: bonam
07/20/2020 21
Discussion
Gitelman
Syndrome
07/20/2020 23
Mutasi melibatkan gen
SLC12A3, yang
kelainan tubular resesif
mengkode sensitif
autosom
thiazide NaCl
cotransporter (NCCT).
07/20/2020 24
Pathophysiology
07/20/2020 25
Clinical manifestations
Severe constipation,
neuromuscular polyuria and
nocturia. hypocalciuria,
symptoms such as
hypomagnesemia,
muscle weakness, in young adults increased thirst with
hypokalemia and
paresthesias, cramps abnormal appetite.
metabolic alkalosis
and tetany episodes stomach ache,
or paralysis In this patientand
vomiting there are clinical
fever
symptoms of vomiting, weakness in
inferior extremity and constipation as
well as a history of fever, fatigue,
thirst, frequent urination especially at
night.
07/20/2020 27
Diagnosis
07/20/2020 28
07/20/2020 29
TREATMENT
Supplements of sodium,
potassium and Targets for potassium Dosage will be titrated
magnesium 3.0 mmol / l and individually (side effects
Supportive magnesium 0.6 mmol / l vs symptoms)
management
33
07/20/2020 34